FEV1/FVC agreement study between two different seasons Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Is spirometry properly used to diagnose COPD? Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012
More than half of patients with COPD in Poland are still smoking, only one third is treated according to GOLD recommendations – Results from PulmoScreen study Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010
Comparative study of FEV1 /FVC and FEV1 /FEV6 to screen COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 511s Year: 2005
The prevalence of COPD in Annaba, Algeria: Results of the BOLD study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Applicability of the global lung initiative (GLI) spirometric reference values for northern Sweden Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
The interaction between family history of COPD, personal smoking and post-bronchodilator airflow obstruction: A cohort study Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
Lung function study in Madagascan children: Spirometric reference values and prevalence of bronchial asthma – The VAVANY-study Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010
Mortality risks of COPD for nonsmokers and smokers from a prospective cohort study of 390,269 subjects in Taiwan – Assessing involvement beyond the lungs Source: Annual Congress 2012 - COPD epidemiology Year: 2012
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Changes in FEV1 over 8 years in COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Waist-to-height ratio and lung function among adults. The PLATINO cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Prospective analysis of lung function in COPD patients – home monitoring of FEV1 and PEF (PIKO®1) Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Restart of smoking results in increased decline in FEV1 - report from the obstructive lung disease in northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001
Predicted spirometric values for Romanian adults – A preliminary study Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013